Description

PHERECYDES PHARMA We are developing bacteriophages to rapidly detect and/or kill a large range of bio threats, including multiresistant, emergent or previously uncharacterized bacteria, to treat people and/or environments. The company owns proprietary methods for accelerated targeted protein evolution, to engineer phages into targetable nano devices.

Service Category(s)
Key Service(s)
Life Science Sector
Certificates
NO DATA